The primary roles of T cells and B cells in the initiation of systemic autoimmunity are unclear.
S
Ystemic autoimmune diseases are the result of complex interactions among T cells, B cells, and target tissues. However, it has been difficult to distinguish the contributions of each cell type in both the initiation of the autoimmune response and the induction of specific pathologic lesions. This is in large part because the dependence of B cell activation on T cells and, reciprocally, the ability of B cells to act as potent APC for T cells.
Evidence of direct roles of T cells and B cells (or secreted Ig) in human lupus has been largely circumstantial. Examples include the presence of T cells in lesions or the presence of autoantibody at sites of inflammation (1) (2) (3) . Animal models, on the other hand, have provided direct evidence for a role of both cell types (4) (5) (6) (7) (8) . Intrinsic T cell defects have been dearly shown in Ipr (9) , BXSB, and NZB-based (10) models.
Furthermore, in autoimmune MRL mice homozygous for the Ipr mutation, thymectomy (11) , anti-Thyl (12), or anti-CD4 (13) antibody treatment ameliorates lymphoproliferation and delaYs autoimmune-mediated inflammation. T cells have also been observed within lesions of affected organs (14) , most notably within the renal interstitium, surrounding vessels, and, to a lesser extent, glomeruli of MRL-Ipr/lpr mice, coincident with the development of nephritis (8, 15) .
There is also evidence of a primary role for autoantibodies and B cells in autoimmune pathogenesis. For example, some but not all anti-DNA antibodies cause nephritis upon injection into normal mice (6, 16, 17) , whereas certain RF cryoglobulins (particularly of the IgG3 subclass) cause vasculitis and nephritis upon injection (18, 19) . The role of B cells in initiating autoimmunity, perhaps by priming or expanding autoreactive T cells, is less clear. Using immunization of normal mice with cross-reactive variants of self-proteins, Lin et al. and Mamula et al. (20, 21) have suggested a key role for B cells in initiating T cell autoreactivity followed by a cascade of additional B cell autoreactivity. B cells from both Ipr/Ipr and NZB mice are intrinsically prone to autoantibody secretion (22) (23) (24) (25) . However, genetic studies have separated the secretion of certain autoantibodies from autoimmune manifestations, indicating that the role of B cells may be complex (26, 27) .
Experiments using strategies to inactivate B cells have suggested their importance in autoimmunity. NZB.xid mice, which have developmentally arrested B cells owing to the xid defect, have a milder form of disease than their NZB counterparts (10) . Similarly, C57Bl/6-1pr/lpr mice, treated with anti-IgM from birth, had few B cells and minimal glomerulonephritis; systemic vasculitis was unaffected (28) . However, because anti-IgM treatment may have effects aside from reduction orb cells, genetic approaches would be helpful to determine whether Ig, B cells, or both are required for disease expression.
For this purpose, the lpr/Ipr model of autoimmunity (29, 30 ) is ideal because fulminant autoimmunity and accumulation of abnormal T cells (31, 32) are controlled by a single recessive gene. Genetic studies are further facilitated by the recent discovery that Ipr is a mutation in theJ~s gene (33) .
The fact that the wild-typefas gene product transduces a signal for apoptosis (33, 34) has important implications for Ipr/lpr autoimmunity. However, how a global J~s defect causes autoimmunity remains unclear, in part becausefas is expressed in many cell types and its regulation is activation dependent (35, 36) . Thus, further work on the cellular contributions to autoimmunity in Ipr/lpr mice is required.
To examine the role of B cells in lpr-induced autoimmunity, in the current studies we have used a novel genetic approach whereby Ipr/Ipr mice were deprived of B cells from birth without exogenous manipulation. We found that these lpr/Ipr mice that lacked B cells failed to develop nephritis or vasculitis. Thus B cells and/or antibody play an important role in the initiation of a wide variety of autoimmune manifestations in lpr/1pr mice.
Materials and Methods

Mice
Jh knockout mice were produced as described (37) and had background genes of 129/Sv and C57B1/6 origin. Mice carrying a single mutant Jh allele were intercrossed at an early stage of propagation, and homozygous mice were identified by PCR assay (see below). These mice were maintained usually by brother-sister rantings. Henceforth, the mutated Jh allele will be referred to as JhD. F1 mice were produced from two separate matings of these homozygousJhD mice with MR.L l lpr/lpr mice. The MR.blprAlor mice were bred at Fox Chase Cancer Center (Phihdelphia, PA) from an original breeding pair obtained from The Jackson Laboratory (Bar Harbor, ME). Three separate 1:2 crosses were set up at the same time. These mice were analyzed at 4.5-6 mo of age, as indicated in the tables and figures.
Genetic Testing
A dual-primer pair PCR assay was used to type for heavy-chain locus genotype. One pair of primers was specific for the Neo gene. These primers were Neo 5' (5'CCTIGCGCAGCTG'IGCTCGAC-GTTG 3') and Neo 3' (5'GCCGCATIGCATCAGCCATGATC, GA 3'). A second pair of primers amplified a region of the locus deleted by the gene targeting Jh 5' (5'GGACCA~AGGTCAC-TCAGG 3') andJh 3' (5' GAGGAGACGGTGACCGTGGTCCCT-GC 3'). Tail DNA preparation and PCR were carried out essentially as described (38) . PCR buffer contained 2.5 mM MgCh. The following thermal cycler temperature program was used: 94~ l-rain initial denaturation; and then 30 cycles of 94~ 30 s/65~ 30 s/72~ 30 s, followed by 2 min at 72~ (MJ Research, Watertown, MA). Mice positive in both assays were considered heterozygotes, whereas mice positive in only one assay were considered homozygotes. FACS ~ analysis agreed with genotyping in all cases tested. A Southern blot assay was used to detect the lpr mutation, using the 180-bp Xba-RI fragment spanning the 5' end of thetis eDNA (33) as a probe. As expected, homozygous mutant mice had a smaller EcoRI fragment than wild-type mice, whereas beterozygotes had both bands at about half the homozygote intensity.
Lymphoproliferation occurred in all mice typed as lpr/Ipr with this assay with the exception of a single mouse (see Results). This mouse also lacked double negative T ceils. Retyping by Southern blot clearly showed this mouse to be a heterozygote. 
Kidney Analysis
Histology. Kidney sections from each animal were analyzed by direct immunofluorescence and light microscopy, as previously described (6, 44) . For direct immunofluorescence, fluoresceinated subclass-specific antisera were used, and the intensity of fluorescence was graded on a scale from 0 to 3 + for the presence and quantity of immune deposits (45) . For fight microscopy, one entire kidney from each animal was fixed in 10% formalin and embedded in paraffin. Multiple 4-/~m sections through the center of the longitudinal axis of each whole kidney were obtained, and they were stained with hematoxylin and eosin.
Microscopic Evaluation. The sections were evaluated by one of us (M. P. Madaio) without knowledge of the donor mouse genotype. The severity of disease in each compartment (glomerular, interstitial, vascular) was graded on semiquantitative scoring of biopsy features (0-3 +) according to previously described methods of Austin et al. (46) , used in the analysis of human lupus nephritis. For purposes of grading in this study, 5-6-too-old MRDlpr/~vr mice with severe disease and 2-too-old normal CBA/J mice were used for comparison (defined as 3 + and 0, respectively). Morphologic analysis involved assessment of the following: (a) for glomerulonephritis: glomerular hyperceLlnlarity (including glomerulm cell proliferation, leukocyte exudation), karyorrhexis and fibrinoid necrosis, luminal occulusion, and cellular crescents; (b) for interstitial nephritis: infiltration of mononudear cells, loss of normal architecture, and tubular necrosis; and (c) for vasculitis: perivascular infiltrates, intimal hyperplasia, and hmiual occuhision.
ELISA~ for Ig and RF
ELISA assays were performed as previously described (38) . Standard titrations were done on each plate, and concentrations were t Abbreviations used in thispaper: BM, bone marrow; DN, double negative for CD4 and CD8; FL, fluorescein; SP, single positive for CD4 or CDS. Numbers are percentages of live lymphocytes, rounded to the nearest whole number. When multiple mice have been analyzed in a group, the SEM is given in parentheses. 1 and Tables 1 and 2 , absence of B cells had no effect on the proportions of these cells in LN or spleen. Whether defined as Thyl + or CD3 + cells, there were no differences in the proportions of DN, CD4 +, or CD8 + SP T cell subsets. In addition, there were similar frequencies of cells that were dull for Thyl, CD3, and B220 ( Fig. 2 and Tables 1 and 2 (49) . This latter conclusion is consistent with the observation in separate staining reactions that nearly all lymphoid cells from the same LN were CD3 + (data not shown). Further muhicolor staining will be required to define the lineage of these cells. Second, we noted in a single +/+ +/+ mouse a population of cells staining brightly for CD3 and B220 (Fig. 2 D) . These B220+/CD3 + cells also stained with anti-IgM but not anti-Thyl. Thus, they probably represent B cells. The reason for the bright CD3 staining is unclear; it does not represent reagent interaction, as most B220 + cells were negative for CD3. It is possible that a subpopulation of B cells expressed high levels of FcR, which bound the anti-CD3 antibody. Unfortunately, because of the experimental design, it was not possible to repeat the staining with different reagents and controls. Since cells falling in the B220b~ig h' CD3 + area were IgM + Thyl-in 
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Anti-B220 ,r Anti-CD4 AutoantibodyProduction. Serum RF activity as well as serum IgG1 and K levels were measured in all mice (Fig. 4) age-related lpr/ltrr-controlled autoantibody production resembling that of MRL-lpr/Ipr mice had ensued among the cohorts of F2 mice.
Ipr/Ipr
Nephritis and Vasculitis. Renal pathology was interpreted
without knowledge of mouse genotypes. The mice could be readily distinguished into two groups with strikingly different morphologies: a group with normal architecture and no immune deposits and a group with severe glomerulonephritis, interstitial nephritis, vasculitis, and both glomerular and interstitial immune deposits. Representative examples are illustrated in Fig. 5 The requirement of B calls for induction of glomerulonephritis substantiates previous work suggesting a role of immune deposits in glomerulonephritis (1, 5, 6, (16) (17) (18) 45) and indicates that immune deposit formation is likely a pivotal event in the initiation of the glomerular lesion. Furthermore, although other systemic and local cellular and cytokine perturbations are present in these animals (53, 54) , they are by themselves insufficient to induce even microscopic disease. In this regard, it will be of particular interest to evaluate cytokine levels within the glomeruli of mice lacking B ceils to determine the influence of B calls and Ig deposition on cytokine disregulation reported to occur before the onset of overt disease (54) .
Absence of interstitial nephritis in Ipr/lpr mice lacking B cells is also interesting and surprising, particularly because of the hypothesis that T cells and macrophages are the primary initiators (4, 55) . It has been reported that intense cellular inflammation often precedes Ig deposits along tubular basement membranes (56) . In addition, T cell lines have been isolated that are nephritogenic upon injection (15) . Our results thus suggest that B cells may be required for the activation of autospecific T cells that infiltrate the kidney. Local cytokine release due to glomerular inflammation could also be required to promote interstitial inflammation (57) .
The role of Ig in the pathogenesis of vasculitis has been controversial (6) (7) (8) 58 (59) and passive autoantibody injection studies (18) have suggested that vaseulitis and glomerulonephritis can occur and be induced separately, implying that they arise by distinct mechanisms. However, further work will be required to distinguish the underlying mechanisms.
Aside from its effect on nephritis, it is interesting that a lack of B cells was associated with reduced accumulation of T cells, which was prominent in the older cohort of mice. It has been proposed by Huang et al. (60) that activation of CD4 + and/or CD8 + SP cells is required for accumulation of DN T cells. Based on the present data, we propose that B cell interaction is an important pathway for such activation. Accumulation of both DN and SP T cells was reduced in mice lacking B cells, suggesting that B cells either interact equally with these subsets to promote their accumulation or else interact with a precursor that contributes equally to these T cell subsets. T cell accumulation is not, however, completely abrogated in the absence of B cells, especially in young animals. This suggests that other cell types, perhaps dendritic cells or macrophages, are also competent to activate precursors of accumulating T cells. The role of B cells in promoting further accumulation would become more apparent as macrophages and dendritic cells become more limiting amid the accumulating T cells in mice lacking B cells. The requirement for B cells to induce maximal lymphoaccumulation further suggests that theJhs defect prevents an apoptotic event, which would normally occur only after T cell interaction (either stimulatory or tolerogenic) with an APC. Whether the Jhs deficiency is also required in the B cell in order to promote T cell accumulation could be tested via reconstitution of B cells in this model system.
In contrast to the periphery, DN T cells were dispropor- (61) . As in the periphery, a lack of B cells required for DN T cell expansion would limit DN T cell generation in the thymus of mice lacking B cells. An assumption inherent in our conclusions is that the phenotypes of homozygous JhD-mutant mice are the result of the lack of B cells. An alternative interpretation is that a genetic locus linked to the JhD mutation on chromosome 12, rather than the mutation itself, is responsible for our findings. A candidate for such a locus, mapped by Watson et al. (62) to chromosome 12, modifies Ipr/lpr renal disease in the MRL background. Although this locus is linked to the Jh locus (most likely ",,40 cM away), it is unlikely that it-rather than the Jh knockout itself-is responsible for the present observations. The locus described by these workers is a "modifying locus" which, along with another unlinked locus, has an effect on the "renal index" that accounts for only "~50% of the variance in renal disease. By contrast, the difference in nephritis in our studies was dramatic: disease was either severe or absent. Thus it is unlikely that this locus accounts solely for our observations. The observation that Ipr/Ipr mice with either one (i.e., JhD/+) or two (i.e., +/+) copies of the MILL-derived chromosome 12 had equally severe disease also supports this conclusion. In light of our data, we suggest that in class II-deficient mice, suboptimal B cell activation because of lack of class II expression may also play a role in preventing nephritis in these mice. Indeed, the MRL-Ipr/Ipr class II-deficient mice lacked serum autoantibodies (63) . In addition, we would predict that, after restoration of CD4 § T cells in these mice through cell transfer, disease would not ensue because of the inability to activate B cells. In any case, it is of great interest that in both class II-deficient lpr/Ipr mice and JhD/JhD Ipr/Ipr mice, B cells are directly affected by the genetic alteration, and nephritis is prevented. Our work underscores the importance of B cells in generating autoimmune-mediated tissue damage. The results indicate that B cells are critical for multiple components of autoimmune-mediated inflammation, including those previously thought to be primarily mediated by humoral autoimmunity (glomerulonephritis), cdlular autoimmunity (interstitial nephritis) or both (vasculitis). These data demonstrate that B cells could be an important target for therapy of systemic autoimmunity. Elimination of B cells or B cell subsets would have distinct advantages over removal of Ig alone (as in plasmapheresis). Pathogenic autoantibodies would be removed more efficiently than in plasmapheresis; moreover, B cell suppression would also ameliorate immune-mediated events requiring cell-cell interaction, such as interstitial nephritis and vasculitis, which would be unaffected by removal of Ig alone. A better understanding of the role of B cells and antibody in inducing autoimmune pathology will be necessary to design appropriate B cell-directed therapy.
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